220 related articles for article (PubMed ID: 11107928)
1. [Why is insulin release from beta cells insufficient in type 2 diabetes?].
Grill V
Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2796-8. PubMed ID: 11107928
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional insulin secretion in type 2 diabetes: role of metabolic abnormalities.
Grill V; Björklund A
Cell Mol Life Sci; 2000 Mar; 57(3):429-40. PubMed ID: 10823244
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor.
Doliba NM; Liu Q; Li C; Chen P; Liu C; Naji A; Matschinsky FM
Mol Metab; 2017 Oct; 6(10):1240-1253. PubMed ID: 29031723
[TBL] [Abstract][Full Text] [Related]
4. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
[TBL] [Abstract][Full Text] [Related]
5. [Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes].
Cerasi E; Ktorza A
Med Sci (Paris); 2007 Oct; 23(10):885-94. PubMed ID: 17937902
[TBL] [Abstract][Full Text] [Related]
6. [And what about diabetes?].
Cerasi E
Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
[TBL] [Abstract][Full Text] [Related]
7. [Contribution of free fatty acids to impairment of insulin secretion and action: mechanism of beta-cell lipotoxicity].
Girard J
Med Sci (Paris); 2003; 19(8-9):827-33. PubMed ID: 14593613
[TBL] [Abstract][Full Text] [Related]
8. [Glucotoxicity and lipotoxicity: factors in the pathogenesis and evolution of type 2 diabetes].
Durruty P; García de los Ríos M
Rev Med Chil; 2001 Jun; 129(6):671-9. PubMed ID: 11510210
[TBL] [Abstract][Full Text] [Related]
9. [Glitazones and pancreatic function].
Girard J
Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S18-23. PubMed ID: 15959401
[TBL] [Abstract][Full Text] [Related]
10. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
[TBL] [Abstract][Full Text] [Related]
11. SIRT6 protects against palmitate-induced pancreatic β-cell dysfunction and apoptosis.
Xiong X; Sun X; Wang Q; Qian X; Zhang Y; Pan X; Dong XC
J Endocrinol; 2016 Nov; 231(2):159-165. PubMed ID: 27601447
[TBL] [Abstract][Full Text] [Related]
12. High-fat diet induces early-onset diabetes in heterozygous Pax6 mutant mice.
Chen Y; Feng R; Wang H; Wei R; Yang J; Wang L; Wang H; Zhang L; Hong TP; Wen J
Diabetes Metab Res Rev; 2014 Sep; 30(6):467-75. PubMed ID: 24925705
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes.
Farret A; Lugo-Garcia L; Galtier F; Gross R; Petit P
Fundam Clin Pharmacol; 2005 Dec; 19(6):647-56. PubMed ID: 16313276
[TBL] [Abstract][Full Text] [Related]
14. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic steatosis in humans: cause or marker of lipotoxicity?
van Raalte DH; van der Zijl NJ; Diamant M
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):478-85. PubMed ID: 20489606
[TBL] [Abstract][Full Text] [Related]
16. K(ATP) channels and islet hormone secretion: new insights and controversies.
Ashcroft FM; Rorsman P
Nat Rev Endocrinol; 2013 Nov; 9(11):660-9. PubMed ID: 24042324
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in insulin secretion in type 2 diabetes mellitus.
Guillausseau PJ; Meas T; Virally M; Laloi-Michelin M; Médeau V; Kevorkian JP
Diabetes Metab; 2008 Feb; 34 Suppl 2():S43-8. PubMed ID: 18640585
[TBL] [Abstract][Full Text] [Related]
18. Loss of coupling between calcium influx, energy consumption and insulin secretion associated with development of hyperglycaemia in the UCD-T2DM rat model of type 2 diabetes.
Rountree AM; Reed BJ; Cummings BP; Jung SR; Stanhope KL; Graham JL; Griffen SC; Hull RL; Havel PJ; Sweet IR
Diabetologia; 2013 Apr; 56(4):803-13. PubMed ID: 23404441
[TBL] [Abstract][Full Text] [Related]
19. IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide.
Weksler-Zangen S; Aharon-Hananel G; Mantzur C; Aouizerat T; Gurgul-Convey E; Raz I; Saada A
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E648-57. PubMed ID: 24425765
[TBL] [Abstract][Full Text] [Related]
20. From obesity to diabetes: why, when and who?
Scheen AJ
Acta Clin Belg; 2000; 55(1):9-15. PubMed ID: 10783502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
